Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial

P Aggarwal1, L Rekwal2, S K Sinha2

  • 1ABVIMS and Dr RML Hospital, New Delhi, India.

Annales De Cardiologie Et D'Angeiologie
|May 8, 2021
PubMed

Insights

No-reflow after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is common. Advanced age, longer reperfusion times, and lower ejection fraction predict this adverse outcome.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Myocardial Infarction Research

Background:

  • No-reflow phenomenon during percutaneous coronary intervention (PCI) is a significant complication in ST-segment elevation myocardial infarction (STEMI) patients.
  • While predictors for primary PCI are studied, data on late presenters, who form the majority in peripheral centers, remains limited.

Purpose of the Study:

  • To identify clinical, angiographic, and procedural predictors of no-reflow in STEMI patients undergoing PCI within seven days of symptom onset.
  • To address the data gap concerning no-reflow predictors in patients with delayed presentation.

Main Methods:

  • A single-center prospective case-control study included 958 STEMI patients undergoing PCI within 7 days.
  • Baseline and angiographic data were collected, and patients were categorized into reflow and no-reflow groups based on myocardial blush grade (MBG).

Main Results:

  • The no-reflow group (18.9% of patients) was characterized by higher mean age, lower admission systolic blood pressure, elevated peak Troponin I, and reduced left ventricular ejection fraction (LVEF).
  • Multivariable analysis identified advanced age, reperfusion time > 6 hours, admission SBP < 100 mmHg, Killip class ≥ 3, LVEF ≤ 35%, low initial MBG, long lesion length, large vessel diameter (>3.5mm), and high thrombus burden as independent predictors of no-reflow.

Conclusions:

  • The no-reflow phenomenon post-PCI for STEMI is complex and influenced by multiple factors.
  • Preprocedural lesion characteristics and early perfusion status are critical determinants of no-reflow outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
227
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
65
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
107
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
72